SRC as a target for anti-cancer drugs
Levitzki, A.
Anti-Cancer Drug Design 11(3): 175-182
1996
ISSN/ISBN: 0266-9536 PMID: 8663905 Document Number: 464936
Document emailed within 1 workday
Related Documents
Zigangirova, N.A.; Fedina, E.D.; Zorina, V.V.; Bortsov, P.A.; Tokarskaia, E.A.; Kariagina, A.S.; Alekseevskiĭ, A.V.; Kraiushkin, M.M.; Zaiakin, E.S.; Iarovenko, V.N.; Gintsburg, A.L. 2009: Target-directed search of anti-virulence drugs Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 71-77Nakagawa, Y.; Ikeda, M.; Tasaki, M.; Saito, K.; Takahashi, K. 2013: The new immunosuppressive drugs for renal transplantation: inhibitors of the mammalian target of rapamycin (mTOR) and anti-thymocyte globulin (Thymoglobulin) Nihon Jinzo Gakkai Shi 55(2): 112-118
Bifulco, M.; Di Marzo, V. 2003: The endocannabinoid system as a target for the development of new drugs for cancer therapy Recenti Progressi in Medicina 94(5): 194-198
McCluskey, A.; Ackland, S.P.; Gardiner, E.; Walkom, C.C.; Sakoff, J.A. 2001: The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design? Anti-Cancer Drug Design 16(6): 291-303
Sobolev, A.S. 2009: Novel modular transporters delivering anticancer drugs and foreign DNA to the nuclei of target cancer cells Journal of BUON: Official Journal of the Balkan Union of Oncology 14(Suppl 1): S33-S42
Tominaga, T. 1999: Recent development of oral anti-cancer drugs for breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(3): 301-307
Wagai, F.; Kinoshita, M.; Shiraki, R.; Watanabe, H.; Kitamura, S. 1982: The direct injection of several anti-cancer drugs into the primary lung cancer lesion through a fiberoptic bronchoscope Nihon Kyobu Shikkan Gakkai Zasshi 20(2): 170-175
Fialová, P.; Vlcek, J. 2004: The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs Vnitrni Lekarstvi 50(11): 858-866
Fouquoire, V. 1996: Anti-cancer drugs. 2 Revue de l'Infirmiere 5: 33-36
Takeda, Y.; Tanaka, N.; Konishi, J. 2012: Combination of trastuzumab, aromatase inhibitor and anti-cancer drugs obtained a good prognosis for an inoperable stage IIi B breast cancer patient with giant skin ulceration Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(4): 629-632
Mileshkin, L.; Sullivan, D. 2011: Access to expensive anti-cancer drugs Journal of Law and Medicine 19(2): 232-243
Tanigawa, N.; Hashida, M.; Sezaki, H.; Fujii, M.; Shiraishi, T.; Harima, Y.; Arimoto, A.; Honda, K.; Hanafusa, T.; Mori, K. 1984: Local administration of anti-cancer drugs Nihon Geka Gakkai Zasshi 85(9): 1143-1146
Avantaggiati, M.L. 2013: Cancer metabolism as a therapeutic target: finding the right target(s) in the context of tumor heterogeneity, evolution, and metabolic plasticity Oncology 27(5): 474; 476-477
Wrześniok, D.; Buszman, E.; Matusiński, B. 2003: Drugs ototoxicity. Part II. Loop diuretics, nonsteroidal anti-inflammatory drugs, antineoplastic and antimalarial drugs Wiadomosci Lekarskie 56(7-8): 369-374
Farmer, K.C.; Goulston, K.; Macrae, F. 1993: Aspirin and non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer Medical Journal of Australia 159(10): 649-650
Kristensen, Jørgen.Schøler.; Bukh, A. 2009: Hematology: experiences with common national reports on new anti-cancer drugs Ugeskrift for Laeger 171(13): 1089
Yamori, T. 1997: A human cell line panel for screening anti-cancer drugs Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(2): 129-135
Dasgupta, K.; Di Cesar, D.; Ghosn, J.; Rajan, R.; Mahmud, S.; Rahme, E. 2006: Association between nonsteroidal anti-inflammatory drugs and prostate cancer occurrence Cancer Journal 12(2): 130-135
McGettigan, P.; Roderick, P.; Mahajan, R.; Kadam, A.; Pollock, A.M. 2015: Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs PLOS Medicine 12(5): E1001826; Discussion E1001826
Asakura, S.; Matsui, T.; Tatsumi, A.; Fujio, A.; Kitano, M.; Kobashi, Y. 1988: A case of malignant pleural mesothelioma and its sensitivity tests for anti-cancer drugs Nihon Kyobu Shikkan Gakkai Zasshi 26(7): 695-699